Cerebrospinal Fluid Shunting in Children with Hydrocephalus and Increased Intracranial Pressure Secondary to Human

Basil Enicker1, Colleen Aldous2

  • 1Department of Neurosurgery, Inkosi Albert Luthuli Central Hospital, KwaZulu-Natal, Durban, South Africa; Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.

World Neurosurgery
|October 13, 2022
PubMed

Insights

Cerebrospinal fluid (CSF) shunting is a viable treatment for hydrocephalus in children with HIV-related cryptococcal meningitis, reducing mortality. This study highlights shunt outcomes in pediatric patients, offering crucial data for managing this rare condition.

Area of Science:

  • Pediatric Neurosurgery
  • Infectious Diseases
  • Critical Care Medicine

Background:

  • Hydrocephalus and increased intracranial pressure (ICP) due to HIV-related cryptococcal meningitis are uncommon in children.
  • The efficacy and outcomes of cerebrospinal fluid (CSF) shunting in this pediatric population are not well-documented.

Purpose of the Study:

  • To report the experience and outcomes of CSF shunting in managing hydrocephalus and increased ICP in children with HIV-related cryptococcal meningitis.
  • To evaluate the role of shunting procedures in this specific pediatric cohort.

Main Methods:

  • Retrospective review of data from a single neurosurgery unit over 14 years.
  • Inclusion of patient demographics, clinical presentation, Glasgow Coma Scale scores, CSF pressure, antiretroviral therapy status, laboratory results, neuroimaging, shunting procedures, complications, and mortality.
  • Analysis of outcomes including mortality and survival rates at 1-year follow-up.

Main Results:

  • Seventeen children underwent CSF shunting, with a median age of 10 years; all were on antiretroviral therapy.
  • Common symptoms included headaches (100%), visual impairment (82%), and seizures (47%), with 88% having elevated CSF opening pressure (>30 cm H2O).
  • Ventriculoperitoneal shunts were most common (82%), with infection and obstruction each occurring in 18% of cases. Mortality was 18%, with 59% alive at 1 year.

Conclusions:

  • CSF shunting, including ventriculoperitoneal and lumboperitoneal shunts, is a critical management option for pediatric hydrocephalus secondary to HIV-related cryptococcal meningitis.
  • Treatment with shunts is effective regardless of CD4 count and can significantly reduce mortality in suitable pediatric patients.
  • This study provides the largest series on CSF shunting for this condition in children, underscoring its importance in reducing mortality.
Abstract